HOME About Us Drug Development News / Events Partnerships Investors Careers Contact
News & Events
BIO-Europe Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

7 November 2018
SunRegen Healthcare was announced as the winner of the BIO-Europe® 2018 Startup Slam competition, held in Copenhagen. Dr Yuhong Dong, Director and co-founder of SunRegen presented on how the company’s therapeutic is a potentially transformative healthcare solution for neurodegenerative eye diseases. More details is published in PR Newwire.

EU flag
European Union's SME Instrument Phase 1 Grant

Date: 20 June 2018
SunRegen has received funding from the European Union’s SME Instrument Phase 1 program under grant agreement No 827153.

EU flag
SunRegen Seed Round Financing

Date: 1 March 2018
SunRegen attracted the eyes of investors and won strong support from industry and academia scientists. On the first anniversary, SunRegen closed its seed round financing to move ahead the promising project for the treatment of neurological disorders.

seed financing
Swiss final of IMAGINE IF!

Date: 3rd October, 2017
SunRegen was awarded a special prize of 3 months free membership of the incubator StartLab at the life science park Biopôle, Lausanne, the first incubator dedicated to life sciences located in the Canton of Vaud.
Full details about the Swiss finals of IMAGINE IF! can be found here
Full details of the IMAGINE IF! global program can be found here

ImagineIf Startlab prize

CTI Approved Phase 3 CTI Coaching

Date: 25 August 2017
In August, SunRegen founder team present its project in the CTI coaching acceptance meeting. The jury acknowledged the potent potential value in the neurodegenerative disorders’ market and showed green light. Swiss CTI will continue to support SunRegen and offered the professional coaching to be executed by Dr. Andreas J. Schulze.

CTI Coaching

CTI Approved Innovation Cheque

Date: 21 August 2017
In order to encourage the research collaboration with Swiss research groups, CTI granted innovation cheque for SunRegen to collaborate with the Brain Mind Institute (BMI) in École polytechnique fédérale de Lausanne (EPFL). The collaboration with EPFL will greatly expend the research capability of SunRegen.

CTI
SunRegen Selected into Phase I of BaseLaunch Accelerator

Date: 10 August 2017
SunRegen project was accepted as a phase I project by BaseLaunch, which is a healthcare accelerator backed by Novartis, Pfizer, Johnson & Johnson, and Roche. (please visit BaseLaunch phase 1 announcement

baselunch
CTI offered CTI Coaching Phase 2

Date: 22 June 2017
After thoroughly checked SunRegen’s business idea, Swiss Commission for Technology and Innovation (CTI) decided to offer CTI coaching phase 2 to SunRegen. CTI coach, Dr. Andreas J. Schulze, will do professional evaluation for SunRegen project.

CTI